864 related articles for article (PubMed ID: 11559564)
1. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
[TBL] [Abstract][Full Text] [Related]
2. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.
Cao W; Jamison SF; Garcia-Blanco MA
RNA; 1997 Dec; 3(12):1456-67. PubMed ID: 9404896
[TBL] [Abstract][Full Text] [Related]
3. Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in Mammalian cells lacking topoisomerase I.
Soret J; Gabut M; Dupon C; Kohlhagen G; Stévenin J; Pommier Y; Tazi J
Cancer Res; 2003 Dec; 63(23):8203-11. PubMed ID: 14678976
[TBL] [Abstract][Full Text] [Related]
4. Poisoning of topoisomerase I by an antitumor indolocarbazole drug: stabilization of topoisomerase I-DNA covalent complexes and specific inhibition of the protein kinase activity.
Labourier E; Riou JF; Prudhomme M; Carrasco C; Bailly C; Tazi J
Cancer Res; 1999 Jan; 59(1):52-5. PubMed ID: 9892183
[TBL] [Abstract][Full Text] [Related]
5. The [U4/U6.U5] tri-snRNP-specific 27K protein is a novel SR protein that can be phosphorylated by the snRNP-associated protein kinase.
Fetzer S; Lauber J; Will CL; Lührmann R
RNA; 1997 Apr; 3(4):344-55. PubMed ID: 9085842
[TBL] [Abstract][Full Text] [Related]
6. cdc2 kinase-mediated phosphorylation of splicing factor SF2/ASF.
Okamoto Y; Onogi H; Honda R; Yasuda H; Wakabayashi T; Nimura Y; Hagiwara M
Biochem Biophys Res Commun; 1998 Aug; 249(3):872-8. PubMed ID: 9731229
[TBL] [Abstract][Full Text] [Related]
7. Specific commitment of different pre-mRNAs to splicing by single SR proteins.
Fu XD
Nature; 1993 Sep; 365(6441):82-5. PubMed ID: 8361546
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation status of the Kep1 protein alters its affinity for its protein binding partner alternative splicing factor ASF/SF2.
Robard C; Daviau A; Di Fruscio M
Biochem J; 2006 Nov; 400(1):91-7. PubMed ID: 16834570
[TBL] [Abstract][Full Text] [Related]
9. A new mechanism of acquisition of drug resistance by partial duplication of topoisomerase I.
Komatani H; Morita M; Sakaizumi N; Fukasawa K; Yoshida E; Okura A; Yoshinari T; Nishimura S
Cancer Res; 1999 Jun; 59(11):2701-8. PubMed ID: 10363995
[TBL] [Abstract][Full Text] [Related]
10. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
[TBL] [Abstract][Full Text] [Related]
11. SR proteins escort the U4/U6.U5 tri-snRNP to the spliceosome.
Roscigno RF; Garcia-Blanco MA
RNA; 1995 Sep; 1(7):692-706. PubMed ID: 7585254
[TBL] [Abstract][Full Text] [Related]
12. Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells.
Eisenreich A; Bogdanov VY; Zakrzewicz A; Pries A; Antoniak S; Poller W; Schultheiss HP; Rauch U
Circ Res; 2009 Mar; 104(5):589-99. PubMed ID: 19168442
[TBL] [Abstract][Full Text] [Related]
13. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
Dauksaite V; Akusjärvi G
Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
[TBL] [Abstract][Full Text] [Related]
14. Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I.
Rossi F; Labourier E; Forné T; Divita G; Derancourt J; Riou JF; Antoine E; Cathala G; Brunel C; Tazi J
Nature; 1996 May; 381(6577):80-2. PubMed ID: 8609994
[TBL] [Abstract][Full Text] [Related]
15. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution.
Colwill K; Pawson T; Andrews B; Prasad J; Manley JL; Bell JC; Duncan PI
EMBO J; 1996 Jan; 15(2):265-75. PubMed ID: 8617202
[TBL] [Abstract][Full Text] [Related]
16. Over-expression of SR-cyclophilin, an interaction partner of nuclear pinin, releases SR family splicing factors from nuclear speckles.
Lin CL; Leu S; Lu MC; Ouyang P
Biochem Biophys Res Commun; 2004 Aug; 321(3):638-47. PubMed ID: 15358154
[TBL] [Abstract][Full Text] [Related]
17. Titration of serine/arginine (SR) splicing factors during adenoviral infection modulates E1A pre-mRNA alternative splicing.
Himmelspach M; Cavaloc Y; Chebli K; Stévenin J; Gattoni R
RNA; 1995 Oct; 1(8):794-806. PubMed ID: 7493325
[TBL] [Abstract][Full Text] [Related]
18. [Phosphorylation of serine-arginine rich proteins--pleiotropic effect of one type posttranslational modification].
Piekiełko-Witkowska A
Postepy Biochem; 2006; 52(4):383-9. PubMed ID: 17536507
[TBL] [Abstract][Full Text] [Related]
19. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.
Hanamura A; Cáceres JF; Mayeda A; Franza BR; Krainer AR
RNA; 1998 Apr; 4(4):430-44. PubMed ID: 9630249
[TBL] [Abstract][Full Text] [Related]
20. ASF/SF2-like maize pre-mRNA splicing factors affect splice site utilization and their transcripts are alternatively spliced.
Gao H; Gordon-Kamm WJ; Lyznik LA
Gene; 2004 Sep; 339():25-37. PubMed ID: 15363843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]